Synergistic effects of (-)-epigallocatechin gallate with (-)- epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9

Cancer Research

Volumn 59, Issue 1, 1999, Pages 44-47

  Suganuma, Masami ^a   Okabe, Sachiko ^a   Kai, Yasuko ^a   Sueoka, Naoko ^a,b   Sueoka, Eisaburo ^a   Fujiki, Hirota ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPICATECHIN; EPIGALLOCATECHIN GALLATE; SULINDAC; TAMOXIFEN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CHEMOPROPHYLAXIS; CYTOKINE RELEASE; DOSE RESPONSE; DRUG MECHANISM; DRUG MIXTURE; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; TEA;

3T3 CELLS; ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CATECHIN; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HUMANS; LUNG NEOPLASMS; MICE; SULINDAC; TAMOXIFEN; TEA; TUMOR CELLS, CULTURED;

EID: 0032953802     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Fujiki, H., Komori, A., and Suganuma, M. Chemoprevention of cancer. In: G. T. Bowden and S. M. Fisher (eds.), Comprehensive Toxicology, Vol. 12, pp. 453-471. New York: Elsevier Science Inc., 1997.
2. NCI, DCPC, Chemoprevention Branch, and Agent Development Committee. Clinical development plan: the extracts green tea polyphenols epigallocatechin gallate. J. Cell. Biochem., 26 (Suppl.): 236-257, 1996.
3. Komori, A., Yatsunami, J., Okabe, S., Abe, S., Hara, K., Suganuma, M., Kim, S-J., and Fujiki, H. Anticarcinogenic activity of green tea polyphenols. Jpn. J. Clin. Oncol. 23: 186-190, 1993.
4. Okabe, S., Suganuma, M., Hayashi, M., Sueoka, E., Komori, A., and Fujiki, H. Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res., 88: 639-643, 1997.
5. Yang, G-y., Liao, J., Kim, K., Yurkow, E. J., and Yang, C. S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis (Lond.), 19: 611-616, 1998.
6. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis (Lond.), 19: 1771-1776, 1998.
7. Imai, K., Suga, K., and Nakachi, K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 26: 769-775, 1997.
8. Suga, K., Imai, K., Sueoka, N., and Nakachi, K. Phase 1 clinical trial with green tea tablets in a Japanese healthy population. Cancer Prev. Intern., 3: 79-88, 1998.
9. Ahmad, N., Feyes, D. K., Nieminen, A-L., Agarwal, R., and Mukhtar, H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J. Natl. Cancer Inst. (Bethesda), 89: 1881-1886, 1997.
10. Piazza, G. A., Rahm, A. L. K., Krutzsch, M., Sperl, G., Paranka, N., S., Gross, P. H., Brendel, K., Burt R. W., Alberts, D. S., Pamukcu, R., and Ahnen, D. J. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res., 55: 3110-3116, 1995.
11. Chen, H., Tritton, T. R., Kenny, N., Absher M., and Chiu, J. F. Tamoxifen induces TGF-β1 activity and apoptosis of human MCF-7 breast cancer cells in vitro. J. Cell. Biochem., 61: 9-17, 1996.
12. Komori, A., Suganuma, M., Okabe, S., Zou, X., Tius, M. A., and Fujiki, H. Canventol inhibits tumor promotion in CD-1 mouse skin through inhibition of tumor necrosis factor α release and of protein isoprenylation. Cancer Res., 53: 3462-3464, 1993.
13. Sueoka, E., Nishiwaki, S., Okabe, S., Iida, N., Suganuma, M., Yano, K., Aoki, K., and Fujiki, H. Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumor necrosis factor-α release in mouse lung tissue. Jpn. J. Cancer Res., 86: 749-755, 1995.
14. Suganuma, M., Okabe, S., Sueoka, E., Iida, N., Komori, A., Kim, S-J., and Fujiki, H. A new process of cancer prevention mediated through inhibition of tumor necrosis factor o expression. Cancer Res., 56: 3711-3715, 1996.
15. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. A. Treatment of colonie and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 328: 1313-1316, 1993.
16. Elder, D. J. E., and Paraskeva, C. COX-2 inhibitors for colorectal cancer, Nat. Med., 4: 392-393, 1998.
17. Sakata, M., Ikeda, T., Imoto, S., Takeshima, K., Enomoto, K., and Kitajima, M. Influence of green tea extract and tamoxifen on murine mammary carcinogenesis and estrogen metabolism. Proc. Jpn. Cancer Assoc., 54: 128, 1995.
18. Nakachi, K., Suemasu, K., Suga, K., Takeo, T., Imai, K., and Higashi, Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res., 89: 254-261, 1998.
19. Khafif, A., Schantz, S. P., Chou, T-C., Edelstein, D., and Sacks, P. G. Quantitation of chemoprevention synergism between (-)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis (Lond.), 19: 419-424, 198.
20. Hong, W. K., and Sporn, M. B. Recent advances in chemoprevention of cancer. Science (Washington DC), 278: 1073-1077, 1997.